Clinical Trial Update: Subcutaneous Interval Lengthening of Vedolizumab for Economic Research [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating longer-interval subcutaneous administrations of vedolizumab for economic research in inflammatory bowel diseases and is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Inflammatory Bowel Diseases | Phase 4 | Status: RECRUITING